Reborn Coffee Announces the Formation of an Advisory Board and Appointment of Hisham Elkoustaf as Chair

Reborn Coffee Announces the Formation of an Advisory Board and Appointment of Hisham Elkoustaf as Chair GlobeNewswire October 23, 2025 New Advisory Board to Drive Innovation and Growth Globally BREA, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Reborn Coffee Inc. (Nasdaq: REBN), a leader in the specialty coffee market, today announced the formation of its […]

Global Drug Delivery Systems (DDS) Market Transforms Amid New Pharma Demands

Global Drug Delivery Systems (DDS) Market Transforms Amid New Pharma Demands New Alira Health Report Reveals Digital and Sustainable Innovations Driving Drug Delivery Market GlobeNewswire October 23, 2025 FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) — Alira Health today released its 2025 Global Drug Delivery System Trends Report, highlighting the rapid evolution of the global

RocketFuel Expands Mass Payout Capabilities with Fiat

RocketFuel Expands Mass Payout Capabilities with Fiat GlobeNewswire October 23, 2025 San Francisco, CA, Oct. 23, 2025 (GLOBE NEWSWIRE) — RocketFuel Blockchain Inc. (OTC: RKFL) (“RocketFuel” or the “Company”) today announced the addition of fiat currency payouts, allowing companies to send payments directly into their recipients' local bank accounts in USD, EUR, CAD, and other

Verizon Expands Home Internet to More Customers with New Lite Plan

Verizon Expands Home Internet to More Customers with New Lite Plan New Verizon Home Internet Lite brings a reliable, affordable internet option to more communities starting at just $25/month with a limited-time offer GlobeNewswire October 23, 2025 NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) — Verizon Home Internet is expanding to more communities across the

Robin Energy Ltd. Reports Results for the Three Months Ended September 30, 2025 and for the Nine Months Ended September 30, 2025.

Robin Energy Ltd. Reports Results for the Three Months Ended September 30, 2025 and for the Nine Months Ended September 30, 2025. GlobeNewswire October 23, 2025 LIMASSOL, Cyprus, Oct. 23, 2025 (GLOBE NEWSWIRE) — Robin Energy Ltd. (NASDAQ: RBNE), (“Robin”, or the “Company”), an international ship-owning company providing energy transportation services globally, today announced its

Construction Back Office Showcases Cost-Saving Solutions at Charlotte Build Expo 2025

Construction Back Office Showcases Cost-Saving Solutions at Charlotte Build Expo 2025 GlobeNewswire October 23, 2025 Charlotte, NC, Oct. 23, 2025 (GLOBE NEWSWIRE) — Construction Back Office successfully participated as an exhibitor at the Charlotte Build Expo 2025, which took place October 15-16 at the Charlotte Convention Center. The company's Booth 214 attracted significant attention from

AiRWA Inc. Announces 1-for-50 Reverse Split

AiRWA Inc. Announces 1-for-50 Reverse Split GlobeNewswire October 23, 2025 Smyrna, Delaware, Oct. 23, 2025 (GLOBE NEWSWIRE) — AiRWA Inc. (Nasdaq: YYAI) (the “Company”) announces that, as previously approved by the stockholders of the Company, it will implement a 1-for-50 reverse stock split of its outstanding shares of common stock (the “Reverse Split”), effective at

UTime Limited Announces MOU to Co-Develop Elderly Care Services Platform

UTime Limited Announces MOU to Co-Develop Elderly Care Services Platform GlobeNewswire October 23, 2025 SHENZHEN, China, Oct. 23, 2025 (GLOBE NEWSWIRE) — UTime Limited (NASDAQ: WTO) (“UTime” or the “Company”) announced today that it has entered into a Memorandum of Understanding (MOU) with Hainan Fuxinyi Investment Co., Ltd. (“Fuxinyi), a company specializing in integrating eldercare

EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India

EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India GlobeNewswire October 23, 2025 SINGAPORE, Oct. 23, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that its wholly-owned subsidiary, CK

GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies

GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies GlobeNewswire October 23, 2025 The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed with no safety or tolerability issues observed, allowing advancement into Cohort 4 with a dose of 10 ug/kg/day

Scroll to Top